Versartis Inc (NASDAQ:VSAR)

1.55
Delayed Data
As of Apr 20
 -0.025 / -1.59%
Today’s Change
1.50
Today|||52-Week Range
22.10
-29.55%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$68.5M

Company Description

Versartis, Inc. engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.

Contact Information

Versartis, Inc.
4200 Bohannon Drive
Menlo Park California 94025
P:(650) 963-8580
Investor Relations:
(650) 516-2703

Employees

Shareholders

Individual stakeholders45.91%
Other institutional36.09%
Mutual fund holders13.29%

Top Executives

Jay P. ShepardPresident, CEO, CFO & Director
Robert GutChief Medical Officer, Head-Clinical & Medical
Paul B. WestbergChief Business Officer & Senior Vice President
Shane M. WardSenior Vice President & General Counsel
Tracy M. WoodyChief Commercial Officer